Press Releases

See below for the latest IPHA press releases. You may subscribe to the Press Releases RSS Feed here.

IPHA Statement on the Report on a Proposed Model for Reference Pricing and Generic Substitution: The Irish Pharmaceutical Healthcare Association (IPHA) notes the publication of the report on a proposed model for Reference Pricing and Generic Substitution and looks forward to further discussions with the Department of Health and Children (DoHC) on the matter.
The development of Ireland as a centre for clinical research would help to embed the pharmaceutical sector in the Irish economy: The Irish Pharmaceutical Healthcare Association (IPHA), the representative body for the international research-based pharmaceutical industry in Ireland, welcomes the publication of the Clinical Research Roadmap by the Irish Clinical Research Infrastructure Network (ICRIN) which defines the necessary steps Ireland needs to take to create a sustainable national system to support clinical research.
A strong and supported pharmaceutical industry is central to Ireland’s economic recovery: The Irish Pharmaceutical Healthcare Association (IPHA) has this morning launched the latest edition of its Pharmaceutical Healthcare Facts and Figures 2010 which presents an overview of healthcare in Ireland and the pharmaceutical industry both nationally and globally. Speaking at the launch, Dr Gerald Farrell, IPHA President stated: “It is clear from our latest edition of Pharmaceutical Healthcare Facts and Figures that the international research-based pharmaceutical industry’s footprint spans the entire island of Ireland. Every day the industry plays a vital role in the lives of Irish patients and consumers. When they fall ill – whether it’s with a cold or something more serious – it is likely that they will take a medicine or treatment to help them get better. Not only that, our industry has key role to play in helping the Irish economy get better too.
medicines.ie certified as trustworthy source of health information by the Health on the Net Foundation: medicines.ie, the medicines information online portal developed by the Irish Pharmaceutical Healthcare Association (IPHA), has been certified as a trustworthy source of health information by the Health on the Net Foundation (HON). Announcing the news, Ms Anne Nolan, IPHA Chief Executive stated that “Patients are being provided with increasing amounts of information from different parties with various objectives sent through multiple channels, particularly the internet. Technology is revolutionising how and when people access information.
Pharmaceutical industry reports successful anti-counterfeit medicines verification pilot project: EFPIA – the voice of the research-based pharmaceutical industry in Europe – of which the Irish Pharmaceutical Healthcare Association (IPHA) is a member, today published the results of their product verification system pilot project. The pilot, held in Sweden between September 2009 and January 2010, successfully demonstrated that a medicine verification system at the point of dispensing, based on a two-dimensional data matrix, is both robust and effective in securing the medicines supply chain.
Lower price of medicines may save Irish patients up to €500 per year: The Irish Pharmaceutical Healthcare Association (IPHA) announced that with effect from today, the 1st February 2010, the cost of long established medicines would be reduced by 40%. IPHA, the representative body for the international research-based pharmaceutical industry in Ireland, has set up a special website on which patients can check to see if their medicines are listed, and the price reduction. The website – www.checkthelist.ie - carries a detailed list of all the medicines and their new, lower prices. A lo-call number – (1890) 876 700 – has also been set up. checkthelist.ie includes some of the most commonly prescribed medicines in the country.
Andrew Witty, CEO GSK, succeeds Arthur Higgins as President of EFPIA: EFPIA, the voice of the research-based pharmaceutical industry in Europe, of which the Irish Pharmaceutical Healthcare Association (IPHA), is a member, welcomes Mr. Andrew Witty as its new President. Mr. Witty, who is CEO of GlaxoSmithKline, officially took up his post on January 1st, 2010, succeeding outgoing President Arthur J. Higgins, CEO of Bayer HealthCare.
Pharmaceutical industry has 23 vaccines in development for HIV/Aids without which infections could double globally: Today marks the 21st anniversary of 'World AIDS Day' - a global awareness campaign that originated at the 1988 World Summit of Ministers of Health on Programmes for AIDS Prevention. HIV/AIDS is one of the most devastating diseases affecting patients around the world. To help fight this global disease, pharmaceutical researchers are currently testing 97 medicines to treat HIV/AIDS and related conditions and intensifying their efforts to develop preventative vaccines. Since first identifying the AIDS virus in 1983, 31 medicines have been approved to treat HIV infection. The first AIDS medicine was approved in 1987 just four years after the virus was identified.
Colette Langan, Country Manager for Bristol Myers Squibb Pharmaceuticals in Ireland and Finland has been appointed to the Strategy Board of the Irish Pharmaceutical Healthcare Association: The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the election of Colette Langan to its Prescription Medicines Division Strategy Board.
“Saving money is important, but so is saving lives.” – Irish Pharmaceutical Healthcare Association President: Irish Pharmaceutical Healthcare Association (IPHA) President Dr Gerald Farrell, in his opening address to the 16th IPHA Annual Meeting, stated that there is a need to change the debate on healthcare expenditure if real progress is to be made in healthcare delivery in the decade ahead.

previous
1 of 4
next

IN THIS SECTION

Press Releases

Related Content